Ipilimumab-Based Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events With Ipilimumab Monotherapy and Combination Therapy With Nivolumab

Abstract

The care step pathways provided represent a proactive, evidence-based, and comprehensive plan to support optimal patient outcomes.